Retasturtide is a recently developed novel GLP-1 receptor agonist demonstrating encouraging results in the treatment of type 2 diabetes. This man-made peptide resembles the actions of naturally produced GLP-1, a https://optimusbookmarks.com/story20775868/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes